Chloramphenicol-resistant Neisseria meningitidis containing catP isolated in Australia

Tiffany R Shultz1, John W Tapsall, Peter A White

  • 1Department of Microbiology, South Eastern Sydney Area Health Services, The Prince of Wales Hospital, Sydney 2031, Australia.

Insights

Two Australian meningococcal strains show chloramphenicol resistance, linked to a mobile genetic element from Clostridium perfringens. This finding is significant given low systemic antibiotic use, suggesting alternative resistance mechanisms.

Area of Science:

  • Microbiology
  • Genetics
  • Infectious Diseases

Background:

  • Chloramphenicol resistance in Neisseria meningitidis has been previously reported in Vietnam and France.
  • Invasive meningococcal disease remains a significant public health concern globally.

Purpose of the Study:

  • To characterize two distinct serogroup B meningococcal strains exhibiting chloramphenicol resistance isolated in Australia.
  • To investigate the genetic basis and potential mechanisms of chloramphenicol resistance in these meningococcal isolates.

Main Methods:

  • Phenotypic testing including disc diffusion, Etest, and agar inclusion Minimum Inhibitory Concentration (MIC).
  • Acetylated chloramphenicol examination.
  • DNA amplification and sequencing to identify resistance genes and mobile genetic elements.

Main Results:

  • Two distinct serogroup B meningococcal strains isolated in Australia (1994 and 1997) demonstrated phenotypic chloramphenicol resistance.
  • Genetic analysis confirmed the presence of catP and the 3' end of tnpV from the mobilizable element Tn4451.
  • Tn4451 was found inserted into the TIGR locus NMB1350 without apparent disruption of virulence genes.

Conclusions:

  • This study reports the second instance of chloramphenicol-resistant meningococci, identified in Australia.
  • The resistance mechanism appears linked to the Tn4451 element, potentially influenced by high topical chloramphenicol use.
  • Current methods for screening and defining chloramphenicol resistance in meningococci require further refinement.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...